MAIN-CAV: Phase III randomized trial of maintenance cabozantinib (CABO) and avelumab (Av) vs Av after first-line platinum-based chemotherapy in patients (pts) with metastatic urothelial cancer (mUC; Alliance A032001) Meeting Abstract

  

Authors:	Gupta, S.; Ballman, K. V.; Apolo, A. B.; Sridhar, S. S.; Chen, R. C.; Wen, Y.; Yen, A. E.; Grivas, P.; Tan, A. L.; Baghaie, S.; Galsky, M. D.; Morris, M. J.; Rosenberg, J. E.
Abstract Title:	MAIN-CAV: Phase III randomized trial of maintenance cabozantinib (CABO) and avelumab (Av) vs Av after first-line platinum-based chemotherapy in patients (pts) with metastatic urothelial cancer (mUC; Alliance A032001)
Meeting Title:	2024 ASCO Genitourinary Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	42
Issue:	4 Suppl.
Meeting Dates:	2024 Jan 25-27
Meeting Location:	San Francisco, CA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2024-02-01
Language:	English
ACCESSION:	WOS:001266676900111
DOI:	10.1200/JCO.2024.42.4_suppl.TPS714
PROVIDER:	wos
Notes:	Meeting Abstract: TPS714 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/219727